174 related articles for article (PubMed ID: 24367252)
21. A recombinant beta-1,3-glucanosyltransferase homolog of Coccidioides posadasii protects mice against coccidioidomycosis.
Delgado N; Xue J; Yu JJ; Hung CY; Cole GT
Infect Immun; 2003 Jun; 71(6):3010-9. PubMed ID: 12761077
[TBL] [Abstract][Full Text] [Related]
22. A recombinant aspartyl protease of Coccidioides posadasii induces protection against pulmonary coccidioidomycosis in mice.
Tarcha EJ; Basrur V; Hung CY; Gardner MJ; Cole GT
Infect Immun; 2006 Jan; 74(1):516-27. PubMed ID: 16369008
[TBL] [Abstract][Full Text] [Related]
23. Vaccines against Coccidioides.
Yoon HJ; Clemons KV
Korean J Intern Med; 2013 Jul; 28(4):403-7. PubMed ID: 23864796
[TBL] [Abstract][Full Text] [Related]
24. Construction and evaluation of a novel recombinant T cell epitope-based vaccine against Coccidioidomycosis.
Hurtgen BJ; Hung CY; Ostroff GR; Levitz SM; Cole GT
Infect Immun; 2012 Nov; 80(11):3960-74. PubMed ID: 22949556
[TBL] [Abstract][Full Text] [Related]
25. Whole glucan particles as a vaccine against systemic coccidioidomycosis.
Clemons KV; Antonysamy MA; Danielson ME; Michel KS; Martinez M; Chen V; Stevens DA
J Med Microbiol; 2015 Oct; 64(10):1237-1243. PubMed ID: 26297127
[TBL] [Abstract][Full Text] [Related]
26. Recombinant urease and urease DNA of Coccidioides immitis elicit an immunoprotective response against coccidioidomycosis in mice.
Li K; Yu JJ; Hung CY; Lehmann PF; Cole GT
Infect Immun; 2001 May; 69(5):2878-87. PubMed ID: 11292702
[TBL] [Abstract][Full Text] [Related]
27. Deficient resistance to Coccidioides immitis following intravenous vaccination. II. Evidence against an immune tolerance mechanism.
Scalarone GM; Levine HB
Sabouraudia; 1971 Jul; 9(2):90-6. PubMed ID: 4939207
[No Abstract] [Full Text] [Related]
28. Deficient resistance to Coccidioides immitis following intravenous vaccination. I. Distribution of spherules after intravenous and intramuscular doses.
Scalarone GM; Levine HB
Sabouraudia; 1971 Jul; 9(2):81-9. PubMed ID: 5111562
[No Abstract] [Full Text] [Related]
29. Flow Cytometric Analysis of Protective T-Cell Response Against Pulmonary Coccidioides Infection.
Hung CY; Wozniak KL; Cole GT
Methods Mol Biol; 2016; 1403():551-66. PubMed ID: 27076153
[TBL] [Abstract][Full Text] [Related]
30. Deficient resistance to Coccidioides immitis following intravenous vaccination. 3. Humoral and cellular responses to intravenous and intramuscular doses.
Levine HB; Scalarone GM
Sabouraudia; 1971 Jul; 9(2):97-108. PubMed ID: 5111563
[No Abstract] [Full Text] [Related]
31. Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. The Valley Fever Vaccine Study Group.
Pappagianis D
Am Rev Respir Dis; 1993 Sep; 148(3):656-60. PubMed ID: 8368636
[TBL] [Abstract][Full Text] [Related]
32. Vaccinated C57BL/6 mice develop protective and memory T cell responses to Coccidioides posadasii infection in the absence of interleukin-10.
Hung CY; Castro-Lopez N; Cole GT
Infect Immun; 2014 Feb; 82(2):903-13. PubMed ID: 24478103
[TBL] [Abstract][Full Text] [Related]
33. Coccidioides immitis vaccine: potential of an alkali-soluble, water-soluble cell wall antigen.
Lecara G; Cox RA; Simpson RB
Infect Immun; 1983 Jan; 39(1):473-5. PubMed ID: 6822433
[TBL] [Abstract][Full Text] [Related]
34. C-type lectin receptors differentially induce th17 cells and vaccine immunity to the endemic mycosis of North America.
Wang H; LeBert V; Hung CY; Galles K; Saijo S; Lin X; Cole GT; Klein BS; Wüthrich M
J Immunol; 2014 Feb; 192(3):1107-1119. PubMed ID: 24391211
[TBL] [Abstract][Full Text] [Related]
35. Genetic vaccination against Coccidioides immitis: comparison of vaccine efficacy of recombinant antigen 2 and antigen 2 cDNA.
Jiang C; Magee DM; Quitugua TN; Cox RA
Infect Immun; 1999 Feb; 67(2):630-5. PubMed ID: 9916069
[TBL] [Abstract][Full Text] [Related]
36. Molecular and cellular mechanisms of protective immunity to coccidioidomycosis.
Kirkland TN; Raz E; Datta SK
Vaccine; 2006 Jan; 24(4):495-500. PubMed ID: 16181709
[TBL] [Abstract][Full Text] [Related]
37. Vaccine immunity to coccidioidomycosis occurs by early activation of three signal pathways of T helper cell response (Th1, Th2, and Th17).
Hung CY; Gonzalez A; Wüthrich M; Klein BS; Cole GT
Infect Immun; 2011 Nov; 79(11):4511-22. PubMed ID: 21859851
[TBL] [Abstract][Full Text] [Related]
38. Maize-Produced Ag2 as a Subunit Vaccine for Valley Fever.
Hayden CA; Hung CY; Zhang H; Negron A; Esquerra R; Ostroff G; Abraham A; Lopez AG; Gonzales JE; Howard JA
J Infect Dis; 2019 Jul; 220(4):615-623. PubMed ID: 31184702
[TBL] [Abstract][Full Text] [Related]
39. Role of B cells in vaccine-induced immunity against coccidioidomycosis.
Magee DM; Friedberg RL; Woitaske MD; Johnston SA; Cox RA
Infect Immun; 2005 Oct; 73(10):7011-3. PubMed ID: 16177382
[TBL] [Abstract][Full Text] [Related]
40. Attributes of deficient immunity in mice receiving Coccidioides immitis Spherule vaccine by the intravenous route.
Scalarone GM; Levine HB
Sabouraudia; 1969 Oct; 7(3):169-77. PubMed ID: 5385153
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]